Fractal Market Hypothesis: Quantification and Usage

Follow us on LinkedIn

The Fractal Market Hypothesis (FMH) is a theory that suggests that financial markets behave in the same way as natural phenomena and are subject to the same physical laws as found in nature. It suggests that financial markets are composed of similar patterns which repeat over and over again at different scales. These patterns can be used to identify market trends and can help investors make more informed decisions.

The Fractal Market Hypothesis is one of the alternatives to the Efficient Market Hypothesis (EMH) which states that all available information is already factored into the price of a security. The other alternative is the Adaptive Market Hypothesis (AMH).

Reference [1] examined how the fractal nature of the financial market can be quantified and used in investment analysis. It pointed out,

This paper examined the fractal properties of developed and developing market indices and examined the evolution of these fractal properties over a two-decade period. The FMH, using empirical evidence, posits that financial time series are self-similar, a feature which arises because of the interaction of investors with different investment horizons and liquidity constraints. The FMH presents a quantitative description of the way financial time series change; so after the testing of observed, empirical properties of financial market prices, forecasts may be formalized. Under the FMH paradigm, liquidity and the heterogeneity of investment horizons are key determinants of market stability, so the FMH embraces potential explanations for the dynamic operation of financial markets, their interaction and inherent instability. During “normal” market conditions, different investor objectives ensure liquidity and orderly price movements, but under stressed conditions, herding behavior dries up liquidity and destabilizes the market through panic selling.

We believe that the indicators presented in the paper can be implemented in trading systems.

Let us know what you think in the comments below or in the discussion forum.

References

[1] A. Karp and Gary Van Vuuren, Investment implications of the fractal market hypothesis, 2019 Annals of Financial Economics 14(01):1950001

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSRajiv Jain-Led GQG’s $10 Billion India Bet Has Winning Picks Beyond Adani
Rajiv Jain-Led GQG’s $10 Billion India Bet Has Winning Picks Beyond Adani

GQG Partners LLC, led by star investor Rajiv Jain, saw the value of its India portfolio more than double in little over a year, driven by winning stock picks that go beyond its headline-grabbing investments in the Adani Group.

Stay up-to-date with the latest news - click here
LATEST NEWSUMC Recognized for ESG Strength With DJSI World & Emerging Markets Index and MSCI-ESG AA Rating
UMC Recognized for ESG Strength With DJSI World & Emerging Markets Index and MSCI-ESG AA Rating

HSINCHU, Taiwan — United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), a leading global semiconductor wafer foundry, today announced its 16th consecutive year of being included in the Dow Jones Sustainability Indices (DJSI) and achieved the top ranking among its semiconductor foundry peers in the…

Stay up-to-date with the latest news - click here
LATEST NEWSUAE takes UN council envoys to Rafah amid dire aid warnings
UAE takes UN council envoys to Rafah amid dire aid warnings
Stay up-to-date with the latest news - click here
LATEST NEWSDollar rises ahead of US inflation data, Fed meeting; yuan heavy
Dollar rises ahead of US inflation data, Fed meeting; yuan heavy
Stay up-to-date with the latest news - click here
LATEST NEWSMaaT Pharma Presents Positive Results with Lead Product MaaT013 and Provides Insights on Ongoing Phase 2b Trial with MaaT033 at ASH 2023
MaaT Pharma Presents Positive Results with Lead Product MaaT013 and Provides Insights on Ongoing Phase 2b Trial with MaaT033 at ASH 2023

Positive efficacy and good safety results from 111 patients with acute graft-versus-host disease (aGvHD) treated with MaaT013 in Early Access Program presented at 2023 ASH Meeting Gastrointestinal overall response rate (GI-ORR) of 53% observed at day 28 positively and significantly impacted overall survival (OS) in…

Stay up-to-date with the latest news - click here

Leave a Reply